-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603.O1.6 603. Oncogenes and Tumor Suppressors: Myeloid Malignancies

Program: Oral and Poster Abstracts
Type: Oral
Monday, December 3, 2018: 2:45 PM-4:15 PM
Room 10 (San Diego Convention Center)
Moderators:
Shayda Hemmati, PhD, Albert Einstein College of Medicine and Ilaria Iacobucci, PhD, Department of Pathology, St. Jude Children's Research Hospital
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Hideaki Mizuno, MD*, Yuki Kagoya, MD, PhD*, Junji Koya, MD, PhD*, Yosuke Masamoto, MD, PhD and Mineo Kurokawa, MD, PhD

Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

3:00 PM

Clara Libbrecht, MD1*, Simone Stefanie Riedel, PhD1*, Jessica Haladyna, BA, MS2* and Kathrin M. Bernt, MD1,3

1Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2University of Colorado Denver Anschutz Medical Campus, Aurora, CO
3Pediatric Oncology, University of Pennsylvania, Philadelphia, PA

3:15 PM

Anuhar Chaturvedi, PhD1*, Michelle Maria Araujo Cruz, PhD1*, Ramya Goparaju, PhD1*, Razif Gabdoulline1*, Renate Schottmann1*, Kerstin Görlich1*, Arnold Kloos1*, Felicitas Thol, MD1, Robert Geffers, PhD2*, Dimitrios Mougiakakos3*, Peter Carmeliet, MD, PhD4*, Arnold Ganser, MD1 and Michael Heuser, MD1

1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Genome Analytics Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany
3University Hospital of Erlangen, Erlangen, Germany
4VIB - Katholieke Universiteit Leuven, Vesalius Research Center, Leuven, Belgium

3:30 PM

Xin He, PhD1*, Yinghui Zhu, PhD2*, Haojie Dong, PhD3*, Sierra Min Li4*, Zonghui Ding, PhD5*, Jie Sun, PhD3*, Juan Du, MD PhD6*, Hanying Wang, PhD3*, Lianjun Zhang, PhD3*, Yudao Shen, PhD7*, Hairui Su, BS, PhD8, Samer K. Khaled, MD9, Dandan Zhao, MD10*, Lei Zhang, PhD11*, Robert Hickey12*, Bin Zhang, PhD3*, Ya-Huei Kuo, PhD13, Xinyang Zhao, PhD14, Jian Jin, PhD7*, Nadia Carlesso, MD, PhD3, Jianjun Chen, PhD15, Yang Xu, MD16*, Guido Marcucci, MD3 and Ling Li, PhD17

1Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Monrovia, CA
2Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, ARCADIA, CA
3Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA
4Department of Information Sciences,, City of Hope Medical Center, Duarte
5Department of Biochemistry and Molecular Biology, Mayo Clinic - Scottsdale, Scottsdale, AZ
6Department of Diabetes Complications & Metabolism, Beckman Research Institute,, City of Hope National Medical Center, duarte
7Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
8Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, AL
9City of Hope, Duarte, CA
10Department of Hematologic Malignancies Translational Science, Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope Medical Center, Duarte, CA
11Translational Biomarker Discovery Core, Beckman Research Institute, City of Hope Medical Center, Duarte, CA
12The Translational Biomarker Discovery Shared Resource, Beckman Research Institute,, City of Hope Medical Center, duarte
13Gehr Family Center for Leukemia Research, Department of Hematologic Malignancies Translational Science, Department of hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA
14Department of Biochemistry and Molecular Genetics, University of Alabama At Birmingham, Birmingham, AL
15Department of Systems Biology, Beckman Research Institute, City of Hope Medical Center, Monrovia, CA
16Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, CHN
17Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Ctr., Beckman Res. Institute, Duarte, CA

3:45 PM

Sho Kubota, PhD1*, Kenji Tokunaga, MD2*, Tomohiro Umezu, PhD3*, Takako Yokomizo, PhD4*, Motohiko Oshima, PhD5*, Eisaku Iwanaga, MD, PhD2*, Norio Asou, MD, Ph.D6, Atsushi Iwama, MD, PhD5,7, Kazuma Ohyashiki, MD, PhD3, Motomi Osato, M.D., PhD8,9 and Goro Sashida, MD, PhD4

1Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences, Kumamoto University, Kumamoto City, KUM, Japan
2Kumamoto University School of Medicine, Kumamoto, JPN
3Department of Hematology, Tokyo Medical University, Tokyo, Japan
4Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences, Kumamoto University, Kumamoto City, Japan
5Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
6Saitama Medical University, International Medical Center, Hidaka, Saitama, Japan
7Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, Tokyo University, Tokyo, Japan
8Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
9Laboratory of Runx Biology, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan

4:00 PM

Karina O. Barbosa, BSc1, Anwesha Ghosh, PhD1*, Anagha Deshpande, PhD1*, Sayantanee Dutta, PhD2*, Scott A. Armstrong, MD, PhD3, Stefan K. Bohlander, MD4,5 and Aniruddha J. Deshpande, PhD1

1Tumor Initiation and Maintenance Program, National Cancer Institute-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA
2Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
3Dana-Farber Cancer Institute, Boston, MA
4Department of Internal Medicine III, University Hospital Grosshadern, Ludwig Maximilians- Universität, Munich (LMU), Munich, Germany
5Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand

*signifies non-member of ASH